Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple microbial biomolecules – non-specific refers to a pharmacological classification used to describe the collective targets of broad-spectrum antimicrobial agents that do not rely on a single molecular interaction. Instead of binding to a specific receptor or enzyme, these agents interact with a wide range of microbial components, including membrane lipids, structural proteins, and nucleic acids (ChEMBL Database; StatPearls: Antiseptics and Disinfectants). This target class is primarily associated with antiseptics and disinfectants, such as alcohols, halogens, and oxidizing agents, which cause rapid and irreversible damage to microbial cells. The biological impact involves the simultaneous disruption of cell wall integrity, denaturation of cytoplasmic proteins, and degradation of genomic material (PubMed: PMC7150068). Because these targets are fundamental to almost all microbial life, agents acting on them typically exhibit a very broad spectrum of activity against bacteria, fungi, and viruses. However, the non-specific nature of these interactions also poses a risk to host tissues, leading to potential cytotoxicity and limiting their use to topical or environmental applications (NIH: National Library of Medicine).
The mechanism of action involves the non-specific chemical or physical disruption of microbial structures, primarily through protein denaturation, membrane lysis, and the oxidation of essential cellular components (StatPearls: Disinfectants and Antiseptics; PubMed: PMC7150068).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple microbial biomolecules – non-specific.